| INTRODUCTION
Ubiquitination governs a multitude of cellular processes and is one of the most common forms of posttranslational protein modifications.
Studies predict that all proteins are ubiquitinated at least once during their lifetimes. 1, 2 While our knowledge of the role of phosphorylation in regulating G-protein-coupled receptor (GPCR) biology is extensive, there is a limited understanding of the diverse pathways by which ubiquitination controls GPCR function including trafficking, subcellular localization, abundance and signaling. GPCRs are the largest family of cell surface receptors expressed in mammals and include over 800 members that control a multitude of physiological functions.
GPCRs respond to a diverse array of extracellular stimuli and signal primarily via heterotrimeric G proteins to elicit cellular responses.
Given the abundance and pleiotropic functions of GPCRs, it is not surprising that dysregulation of GPCR signaling has been implicated in numerous diseases and has made this receptor class the largest target for FDA-approved drugs. 3 The first characterized role for ubiquitin as a GPCR endolysosomal sorting signal was discovered in the yeast Saccharomyces cerevisiae. The yeast Ste2 pheromone receptor requires direct ubiquitination for internalization from the plasma membrane. 4, 5 Furthermore, discoveries in S. cerevisiae identified the role for ubiquitin in the sorting of Ste3 at the limiting membrane of the vacuole. 6 These discoveries paralleled investigations into the ubiquitin-dependent vacuolar trafficking of other transmembrane proteins, resulting in the discovery and classification of the Endosomal Sorting Complexes
Required for Transport (ESCRT) machinery [7] [8] [9] as well as the diversity of ubiquitin-binding adaptor proteins involved in early and late endocytosis. [10] [11] [12] In addition, ubiquitin promotes endocytic adaptor scaffolding during the internalization of GPCRs. 13, 14 These studies demonstrated the critical role of ubiquitin in GPCR regulation, and stimulated the study of ubiquitin in the endocytic sorting and lysosomal degradation of mammalian GPCRs as discussed below.
Ubiquitination likely offers novel and diverse mechanisms for regulation of GPCR biology. Therefore, a thorough understanding of the mechanisms by which key regulators and mediators of ubiquitination regulate GPCR signaling and trafficking is needed for defining dysregulated mechanisms in disease and identifying new targets for drug development for the treatment of human diseases. While ubiquitination of GPCRs has been largely ascribed to lysosomal or proteasomal degradation, emerging studies provide new insight into the multifaceted and diverse functions of ubiquitin in regulating GPCR endolysosomal sorting and signaling. Here, we discuss the various GPCR endo-lysosomal sorting pathways that are conveyed through direct and indirect GPCR ubiquitination as well as the role of ubiquitination in regulating key endocytic adaptor proteins that facilitate GPCR endo-lysosomal sorting and new functions of ubiquitin in regulating GPCR biology.
| DIRECT UBIQUITINATION OF GPCRS AND ENDO-LYSOSOMAL SORTING
One of the most well-studied signals that direct GPCRs through the endo-lysosomal system is the covalent attachment of ubiquitin. represents another ubiquitin-independent pathway for GPCR degradation. 18 Interestingly, the recovery of ubiquitin-independent GPCRs like the DOR from the limiting membrane of the late endosome to the plasma membrane has also been observed, 19 suggesting that these lysosomal pathways are also dynamically regulated. This section will discuss the most recent findings regarding the factors that control GPCR sorting at the limiting membrane of late endosomes and lysosomal degradation.
Ubiquitin is covalently attached to cytoplasmic lysine residues of target substrates, and the ubiquitin signal that directs GPCRs to the lysosome occurs on distinct cytoplasmic regions ( Figure 1 ). GPCRs contain three ICLs and a carboxyl-terminal tail that are exposed to the cytoplasm and are accessible by E3 ubiquitin ligases. Ubiquitination of the C-terminal tail is sufficient to mediate lysosomal sorting of the chemokine C-X-C motif receptor type 4 (CXCR4) 20 and the κ-opioid receptor. 21 More recently, agonist-induced ubiquitination of the γ-aminobutyric acid receptor (GABA B ) B1 subunit C-terminus has been demonstrated in live cells using BRET. 22 In contrast, the V 2 vasopressin receptor is ubiquitinated primarily in ICL3. 23 The prototypical ubiquitin-dependent cargo, the β2-adrenergic receptor (β2AR), is specifically ubiquitinated on lysine residues within both its ICL3 and Cterminal tail prior to lysosomal degradation. 24 Furthermore, ubiquitination of the μ-opioid receptor ICL1 is a rate-limiting step in the packaging of the receptor into intraluminal vesicles prior to uptake by MVBs. 25 ( Figure 2B ) and the GABA B(B1) subunit. 22 Here, USP14 appears to function as an adaptor protein that facilitates packaging of receptors into budding intraluminal vesicles of MVBs. These results demonstrate that the dynamic cycle of GPCR ubiquitination, rather than the ubiquitination state of the receptor, is also critical for endo-lysosomal receptor trafficking.
Ubiquitin is not the only endo-lysosomal sorting signal, and multiple GPCRs have been shown to harbor other sorting sequences that facilitate binding to late endosomal sorting adaptors, this is best characterized for PAR1. Although PAR1 is ubiquitinated upon agonist stimulation, 28,34 receptor ubiquitination is not required for endolysosomal sorting. Instead, PAR1 sorting from early endosomes to late endosomes requires a YXXϕ (where X is any amino acid and ϕ can be any bulky hydrophobic amino acid) within its C-terminal tail which is bound by the heterotetrameric adaptor protein complex-3 (AP-3), a clathrin adaptor protein complex. 35 Once at the limiting membrane of the late endosome, PAR1 interacts with the adaptor protein ALIX via a highly conserved YPX 3 L motif localized within ICL2 16 ( Figure 2C ).
The ICL2 of purinergic receptor P2Y 1 also harbors a conserved YPX 3 L motif that directs receptor sorted to lysosomes in an ALIX-dependent manner 17 ( Figure 1 ). ALIX directs receptors into budding intraluminal vesicles and couples YPX 3 L-motif GPCRs to the ESCRT-III complex.
Similarly, lysosomal sorting of the DOR 36 and the D2 dopamine receptor 37 is mediated by the adaptor protein GASP-1, which couples these proteins to the ESCRT-0 complex independent of receptor ubiquitina- to the trans-golgi network, 19 where it can be re-sorted to the plasma membrane. These findings demonstrate that ALIX, GASP-1 and potentially other late endosomal adaptor proteins can mediate the endolysosomal trafficking, in some cases independent of ubiquitin and certain canonical ESCRT components, expanding the diversity of lysosomal sorting mechanisms for GPCRs beyond the direct ubiquitination and canonical ESCRTs.
| INDIRECT UBIQUITIN-MEDIATED GPCR ENDO-LYSOSOMAL SORTING VIA MODULATION OF ENDOCYTIC ADAPTOR PROTEINS
In addition to direct ubiquitination of GPCRs, targeting of receptors to the endo-lysosomal pathway is controlled by ubiquitination of various endocytic adaptor proteins. β-arrestins are multifunctional adaptor proteins that directly regulate GPCR uncoupling from heterotrimeric G proteins, internalization from the plasma membrane and can facilitate a second wave of signaling in various subcellular compartments.
β-arrestins are comprised of two major N-and C-domains, which consist primarily of β-sheets, an embedded polar core and an extended cytoplasmic tail that contains recognition motifs for clathrin and the AP-2 subunit β-adaptin and is rapidly recruited to agonist-activated GPCRs at the plasma membrane. β-arrestins engage activated GPCRs through interaction with a phosphate sensor mediated by the polar core and activation sensor conferred most notably by the finger loop that is exposed upon interaction with agonist-bound receptor. 38, 39 While the precise conformation of the finger loop bound to the GPCR is not known, arrestin interacts with a highly conserved binding crevice of the GPCR that is similar to the region bound by the Gα subunit C-terminus. 40 Similar to GPCRs, posttranslational modifications of β-arrestins with ubiquitin is critical for regulating their function in controlling GPCR trafficking.
Ubiquitination of β-arrestin was shown to occur in response to β2AR stimulation and is mediated by the E3 ligase mouse double minute-2 (MDM2), and important for stabilizing the β-arrestin/β2AR complex ( Figure 2A ). The increased stability of the β-arrestin/β2AR interaction facilitates β2AR internalization by increasing interaction with components of the endocytic machinery. 41, 42 Ubiquitination of β-arrestins has also been implicated in facilitating GPCR-induced mitogen-activated protein kinase (MAPK) signaling. 41 While MDM2 is important for stabilizing β2-arrestin/β2AR interaction and requires β-arrestin-2 for ubiquitination, MDM2 is selective in mediating β-arrestin ubiquitination and does not ubiquitinate β2AR. However, β-arrestin-2 is required for NEDD4-1 recruitment and ubiquitination of activated β2AR in response to stimulation by its full agonist isoproterenol, which is critical for β2AR endo-lysosomal sorting 43, 44 ( Figure 2A ). Deubiquitination of β-arrestins is also regulated by agonist-activation of the β2AR and other GPCRs and is mediated by USP20 and USP33 and is important for β-arrestin-β2AR complex disassembly, lysosomal sorting and signaling 31, 42 ( Figure 2A ). USP33 also mediates V2 vasopressin receptor-induced β-arrestin deubiquitination, endocytic trafficking and signaling using a similar process. 42 These studies indicate that ubiquitination of β-arrestins influences may aspects of GPCR function including endo-lysosomal sorting by enhancing E3 ligase recruitment and subsequent ubiquitination of the receptor.
In addition to ubiquitination of β-arrestins, agonist-activation of CXCR4 stimulates ubiquitination of ESCRT-0 components, which control CXCR4 endo-lysosomal sorting. In this case, the E3 ligase AIP4 (also known as ITCH), mediates ubiquitination of CXCR4 as well as the ESCRT-0 components, HRS and STAM, which have opposing functions in regulating CXCR4 endo-lysosomal sorting 45, 46 ( Figure 2B ). Ubiquitination of HRS and STAM are regulated through a complex interplay mediated by β-arrestin-1 and AIP4 and is further controlled by the E3 ligase Deltex, which appears to regulate the activity of AIP4 47, 48 ( Figure 2B ). Besides CXCR4, surprising few other GPCRs have been shown to require both direct ubiquitination and components of the canonical ESCRT machinery for endolysosomal sorting and they include the DOR 49 and PAR2, 50 but whether these GPCRs modify the ubiquitination status of ESCRT components to regulate their fate in the endo-lysosomal sorting pathway is not known.
As discussed above, a subset of GPCRs including PAR1 and P2Y 1 are targeted to the endo-lysosomal sorting pathway independent of ubiquitination. While ubiquitination of these GPCRs is dispensable degradation, ubiquitination of the adaptor protein ALIX is important for shuttling the receptors through the endo-lysosomal sorting pathway. We found that ALIX activity is regulated by ubiquitination induced by agonist-activation of PAR1. 51 Ubiquitination of ALIX is mediated by the E3 ligase WWP2 and results in ALIX dimerization and enhanced activity at sorting PAR1 to MVBs/lysosomes. 51 Importantly, the α-arrestin domain-containing protein-3 (ARRDC3) is responsible for activated PAR1-stimulated recruitment of the WWP2 to ALIX and subsequent ubiquitination ( Figure 2C ).
We further showed that ARRDC3 is required for agonist-induced PAR1 interaction with ALIX and lysosomal degradation. 51 The P2Y 1 receptor is also trafficked through a ubiquitin-independent and ALIX-dependent endo-lysosomal sorting pathway like PAR1, 17 suggesting that this pathway is broadly applicable to other GPCRs.
Indeed, besides PAR1, seven other mammalian GPCRs were found to possess conserved ALIX YPX n L-binding motifs within their second ICL, including the adrenoreceptor α1 B , angiotensin receptor AT2, galanin receptor GAL 2 , histamine receptor H 2 , neuropeptide FF receptor NPFF2, neuropeptide S receptor NPS and purinergic receptor P2Y 1. 16 Moreover, ALIX has also been shown to bind to several other GPCRs that lack YPX n L motifs, including the vasopressin V2R and D1-like and D3 dopamine receptors, and regulate receptor trafficking. 52, 53 These studies indicate that ALIX is likely to interact with receptors using divergent types of YPX n L motifs, including directly with ubiquitin. ALIX harbors ubiquitin-binding sites and has been shown to bind directly with K63-linked ubiquitin and may recognize cargo via this mode of interaction. 54 Together, these studies illustrate that GPCR signaling can modulate the activity of the endo-lysosomal sorting machinery through ubiquitination of critical endocytic adaptor proteins and thereby has the capacity to regulate their own endo-lysosomal sorting efficiency. , phospholipids and regulates NEDD4 cellular localization, whereas the WW domains mediate substrate recognition via P/LPxY motifs and phosphorylated serine/threonine residues. The activity of NEDD4 E3 ligases is regulated through release of an auto-inhibited state, which occurs through poorly understood allosteric mechanisms mediated by interactions with the C2 and WW domains. 58 Although numerous studies have implicated NEDD4 E3 ligase function in controlling GPCR endo-lysosomal sorting, 43, 46 it is not known how NEDD4 E3 ligases are released from auto-inhibition to increase HECT ubiquitin ligase activity following GPCR stimulation.
| UBIQUITIN E3 LIGASES FUNCTION IN DIRECT AND INDIRECT REGULATION OF GPCR ENDO-LYSOSOMAL SORTING
One mechanism by which NEDD4 E3 ligase catalytic activity is directed toward GPCRs occurs through recruitment to the receptor.
Several studies have provided insight regarding mechanisms of NEDD4 E3 ligase recruitment and indicate that recruitment of NEDD4 E3 ligases to activated and phosphorylated GPCRs can occur either directly via recognition of receptor serine/threonine phosphorylated residues or indirectly via interaction with endocytic adaptor proteins. 43, 59 This was first illustrated for the β 2 AR and CXCR4. β 2 AR activation results in phosphorylation and binding of β-arrestins, which are both required for agonist-induced β 2 AR ubiquitination. 60 In this case, the β-arrestin-2 isoform functions as the critical adaptor for NEDD4-1 recruitment to activated and phosphorylated β 2 AR. 43 Similarly, agonist-induced ubiquitination of the V2 vasopressin and μ-opioid receptor also requires β-arrestins. 61 Like other NEDD4 family members, the WW domains of NEDD4-1 mediate interaction with substrate proteins through recognition of PPXY motifs. However, PPXY motifs are absent in β-arrestins, indicating that β-arrestinmediated recruitment of NEDD4 E3 ligases is mediated via distinct mechanisms. Despite the lack of PPXY motifs, β-arrestin-1 interacts with AIP4 via WW domains, 47 whereas for NEDD4 interaction with β-arrestin-2 occurs via a non-WW domain region. 43 Unlike β-arrestins, the α-arrestin ARRDC3 contains an extended C-terminal region that harbors PPXY motifs that bind to WW domains of several NEDD4 E3 ligases and has been implicated in NEDD4-1 recruitment to activated β2AR. 44, 60 Intriguingly, however, depletion of ARRDC3 by RNAi failed to perturb β2AR ubiquitination and receptor trafficking, suggesting that ARRDC3 may function secondarily by controlling β2AR endosomal retention. 62 In contrast to β2AR and μ-opioid receptor, the AIP4 is directly recruited to activated CXCR4 via WW domain interaction with phosphorylated serine residues in the C-tail domain of the receptor and occurs independent of β-arrestins. 59 These studies clearly indicate that different GPCRs use distinct direct and indirect mechanisms to recruit NEDD4 E3 ligases, making it difficult to predict how the catalytic activity of NEDD4 E3 ligases is specifically targeted toward certain GPCRs. However, to our knowledge virtually no studies have examined whether recruitment of NEDD4 E3 ligases to GPCRs modulates the catalytic activity of the enzymes or addressed how GPCRs "turn-on" E3 ligase activity, which is exquisitely regulated.
In addition to β2AR and CXCR4, PAR1 ubiquitination and function are well characterized. However, in contrast to these classic GPCRs, ubiquitination of PAR1 mediates p38 MAPK inflammatory signaling and not endo-lysosomal sorting. We previously showed that phosphorylation of PAR1 is required for agonist-stimulated ubiquitination. 34 In recent work, we further demonstrated that NEDD4-2 E3
ligase is rapidly recruited to and ubiquitinates PAR1 following ligand stimulation 28, 63 ( Figure 2C ). However, it is not known if phosphorylation of PAR1 mediates recruitment of "active" NEDD4-2 to the receptor or enables PAR1 internalization and localization to endocytic vesicles containing "active" NEDD4-2 to facilitate substrate-enzyme interaction and ubiquitination.
It is also possible that GPCR signaling triggers NEDD4-2 catalytic activity and was recently examined for PAR1 and the P2Y 1 receptor.
Unexpectedly, we discovered that PAR1 stimulates c-Src-mediated tyrosine phosphorylation and activation of NEDD4-2, which promotes p38 inflammatory signaling 63 ( Figure 2C ). Intriguingly, c-Src is acti- Whether other GPCRs use a similar mechanism to activate NEDD4 E3
ligases to facilitate endo-lysosomal sorting or other functions is not known.
| ALTERNATIVE DESTINATIONS FOR GPCRS-AUTOPHAGY, EXOSOME PACKAGING AND THE PROTEASOME
Recent discoveries have demonstrated that GPCRs can be trafficked to unexpected destinations, highlighting novel functions for GPCRs in regulating cellular homeostasis. The proteasome has emerged as a critical regulator of GPCR expression, and multiple findings have supported specific mechanisms for targeting the removal of GPCRs from endo-membranes prior to proteasomal degradation in the cytoplasm.
Similarly, the relationship between GPCRs and autophagosomes has become an important research topic, as GPCRs are trafficked to autophagosomes in response to cell stress, while autophagosomes can also play an important role in regulating the recycling of some receptors. In addition, GPCR signaling can directly regulate autophagosome biogenesis, enhancing chemotaxis and inhibiting apoptosis. Autophagosomes are highly regulated membrane-bound organelles that degrade cellular components in response to cellular stress.
One aspect of cellular response to stress is redistribution of specific GPCRs to autophagosomes ( Figure 3 ). For example, the β2AR is sorted to autophagosomes under physiologically stressful conditions or persistent β2AR signaling. 68 This process requires the protein kinase A-dependent phosphorylation and deactivation of the DUB USP20, allowing for the ubiquitination of β2AR to persist and act as a sorting signal to autophagosomes. 68 In addition, autophagosome-specific adaptor proteins like Beclin 2 are involved in GPCR degradation.
Beclin-2 interacts with the adaptor protein GASP-1, mediating the degradation of DOR. 69 Figure 3 ). In addition, highly metastatic breast cancer cells release the GPCR S1P 2 in exosomes that can initiate proliferation in nearby fibroblasts. 77 The S1P 2 receptor isolated from MDA-MB-231 breast cancer ECVs is constitutively active due to cleavage of its N-terminus, and can signal to the ERK1/2 MAPK signaling pathway once transferred to fibroblasts 77 ing. This work also provides the first example of how activation of a GPCR "turns-on" an E3 ubiquitin ligase to trigger ubiquitin-driven signaling. Besides lysosomes, GPCRs can be targeted to alternative destinations within the cell including proteasomes, exosomes and the autophagic pathway; however, the mechanisms and role of ubiquitin that regulated GPCR sorting to these pathways are even less clear.
Given the prevalence of ubiquitination, it is likely that all GPCRs are ubiquitinated at least once during their lifetimes, the challenge now is to determine how and why GPCRs are modified with ubiquitin.
ACKNOWLEDGMENTS
This work was supported, in whole or in part by the National Institutes of Health (NIH)/NIGMS R35 GM127121 (J.T) and UC TRDRP 26IP-0050 (J.T.)
CONFLICTS OF INTEREST
The authors have no conflicts of interest to report.
The Editorial Process File is available in the online version of this article.
ORCID
Michael R. Dores https://orcid.org/0000-0001-9243-0582
JoAnn Trejo https://orcid.org/0000-0003-4405-6228
